KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 76 filers reported holding KRYSTAL BIOTECH INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $41,051 | +24.4% | 349,669 | -15.1% | 1.27% | -35.1% |
| Q1 2023 | $32,991 | +4.1% | 412,082 | +3.0% | 1.96% | +10.8% |
| Q4 2022 | $31,688 | -99.9% | 400,000 | -20.0% | 1.77% | +19.0% |
| Q3 2022 | $34,850,000 | +6.2% | 500,000 | 0.0% | 1.49% | -15.2% |
| Q2 2022 | $32,830,000 | -1.3% | 500,000 | 0.0% | 1.75% | +25.8% |
| Q1 2022 | $33,270,000 | -32.1% | 500,000 | -28.6% | 1.39% | +4.8% |
| Q4 2021 | $48,965,000 | +87.6% | 700,000 | +40.0% | 1.33% | +127.6% |
| Q3 2021 | $26,105,000 | -23.2% | 500,000 | 0.0% | 0.58% | -15.4% |
| Q2 2021 | $34,000,000 | -11.7% | 500,000 | 0.0% | 0.69% | +1.3% |
| Q1 2021 | $38,520,000 | +170.3% | 500,000 | +110.5% | 0.68% | +122.5% |
| Q4 2020 | $14,250,000 | +39.4% | 237,500 | 0.0% | 0.31% | +23.4% |
| Q3 2020 | $10,224,000 | +23.4% | 237,500 | +18.8% | 0.25% | +6.9% |
| Q2 2020 | $8,284,000 | +91.6% | 200,000 | +100.0% | 0.23% | +26.8% |
| Q1 2020 | $4,324,000 | -2.4% | 100,000 | +25.0% | 0.18% | +7.0% |
| Q4 2019 | $4,430,000 | -15.0% | 80,000 | -46.7% | 0.17% | -18.2% |
| Q3 2019 | $5,209,000 | -56.9% | 150,000 | -50.0% | 0.21% | -57.3% |
| Q2 2019 | $12,081,000 | +22.4% | 300,000 | 0.0% | 0.49% | +21.3% |
| Q1 2019 | $9,870,000 | +72.7% | 300,000 | +9.1% | 0.40% | +90.1% |
| Q4 2018 | $5,715,000 | +116.7% | 275,000 | +83.3% | 0.21% | +207.2% |
| Q3 2018 | $2,637,000 | +18.2% | 150,000 | 0.0% | 0.07% | +46.8% |
| Q2 2018 | $2,231,000 | +47.4% | 150,000 | 0.0% | 0.05% | +147.4% |
| Q1 2018 | $1,514,000 | -4.1% | 150,000 | 0.0% | 0.02% | -20.8% |
| Q4 2017 | $1,578,000 | +58.3% | 150,000 | +50.0% | 0.02% | +41.2% |
| Q3 2017 | $997,000 | – | 100,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 2,003,367 | $232,390,572 | 11.06% |
| Frazier Life Sciences Management, L.P. | 988,460 | $114,661,360 | 7.62% |
| S Squared Technology, LLC | 108,215 | $12,552,940 | 6.77% |
| Avoro Capital Advisors LLC | 2,565,555 | $297,604,380 | 4.64% |
| APIS CAPITAL ADVISORS, LLC | 24,000 | $2,784,000 | 3.61% |
| Nicholas Investment Partners, LP | 355,611 | $41,250,876 | 3.08% |
| Ghost Tree Capital, LLC | 80,000 | $9,280,000 | 3.05% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 71,531 | $8,297,596 | 2.52% |
| Affinity Asset Advisors, LLC | 57,500 | $6,670,000 | 1.88% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 46,092 | $5,344,828 | 1.80% |